China left atrial appendage closure devices market to grow at 5% CAGR through 2033, forecasts GlobalData

The increasing prevalence of atrial fibrillation (AFib) and growing awareness of stroke prevention are the key factors driving the demand for left atrial appendage (LAA) closure devices in China. In this context, China’s LAA closure devices market is projected to grow at a compound annual growth rate (CAGR) of around 5 per cent through 2033, forecasts GlobalData.

A significant development in this space is the recent regulatory approval of AtriCure’s AtriClip system by China’s National Medical Products Administration (NMPA). This approval represents a critical step forward, addressing the increasing need for effective stroke prevention strategies, particularly among AFib patients in China.

GlobalData’s report, “Structural Heart Occlusion Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033,” reveals that AtriCure commands a substantial 35 per cent share of the Asia-Pacific structural heart occlusion device market, underscoring the company’s influence in the region.

Jyoti Sharma, Medical Devices Analyst at GlobalData, states, “AtriCure’s focus on bringing innovative solutions to the market is likely to push competitors to enhance their product offerings and strategies. This competitive environment is expected to drive increased investment in research and development, ultimately benefiting patients by elevating the standard of care.”

Additionally, AtriCure’s commitment to providing comprehensive training and support to healthcare professionals in China is expected to have both immediate and lasting effects on AFib treatment, leading to better outcomes and more effective stroke prevention measures.

“As the market evolves, GlobalData expects a landscape marked by continuous innovation and a strong focus on delivering high-quality care. This dynamic will play a key role in shaping the future of cardiovascular treatment in China, ensuring that patients have access to the most advanced and effective interventions available,” adds Sharma.